| Date Filed | Type | Description |
| 05/31/2023 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 120,000 shares
@ $0 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Bought 26,000 shares
@ $2.039, valued at
$53k
|
|
| 03/15/2023 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Bought 100,000 shares
@ $2.01, valued at
$201k
|
|
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4/A
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 150,000 shares
@ $0
Paid exercise price by delivering 48,752 shares
@ $13.89, valued at
$677.2k
Granted 63,000 shares
@ $0
Granted 107,000 options to buy
@ $13.89, valued at
$1.5M
|
|
| 01/05/2022 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 150,000 shares
@ $0
Paid exercise price by delivering 48,752 shares
@ $13.89, valued at
$677.2k
Granted 63,000 shares
@ $0
Granted 107,000 options to buy
@ $13.89, valued at
$1.5M
|
|
| 12/30/2021 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 31,728 shares
@ $12.98, valued at
$411.8k
Gifted 20,000 shares
@ $0 |
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/07/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/02/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 190,000 options to buy
@ $4.8, valued at
$912k
|
|
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2018 |
SC 13D/A
| KIDRON NADAV reports a 14.8% stake in Oramed Pharmaceuticals Inc. |
| 07/12/2018 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 61 shares
@ $5.9831, valued at
$365
Bought 122 shares
@ $5.9195, valued at
$722.2 |
|
| 02/02/2018 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 97,000 options to buy
@ $8.14, valued at
$789.6k
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2015 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/03/2014 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/11/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/09/2012 |
4
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 864,000 options to buy
@ $0.34, valued at
$293.8k
|
|
| 05/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2006 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |